Affiliations 

  • 1 Department of Urology, Hospital Covadonga, Córdoba, México
  • 2 Department of Urology, Hospital Universitario "Dr. José Eleuterio Gonzalez", Monterrey, México
  • 3 Department of Surgery, S.H. Ho Urology Centre, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China
  • 4 Department of Urology, Marmara University School of Medicine, Istanbul, Turkey
  • 5 Department of Urology, Hospital Central Militar, México City, México
  • 6 Department of Urology, Hospital Israelita Albert Einstein, BP-a Beneficência Portuguesa de São Paulo, Sao Paulo, Brazil
  • 7 Department of Urology, University Surgical Cluster, National University Hospital, Singapore, Singapore
  • 8 Department Urology, Christian Medical College, Vellore, Tamilnad, India
  • 9 Department Urology, Hospital General de México "Dr. Eduardo Liceaga", México City, México
  • 10 Department of Urology, Hospital Regional de Alta Especialidad de la Peninsula de Yucatán, Mérida, México
  • 11 Department Urology, Asian Institute of Nephrology and Urology, Hyderabad, India
  • 12 Department Urology, King Abdulaziz National Guard Hospital, Riyadh, Saudi Arabia
  • 13 Division of Urology, Department of Surgery, University of Malaya, Kuala Lumpur, Malaysia
  • 14 Department of Urology, Central Military Hospital, Mexico City, Mexico
  • 15 National Academy of Medical Sciences, Bir Hospital and B&B Hospital, Gwarko Lalitpur, Nepal
  • 16 Department of Urology, University Hospital Mohammed the VI of Marrakesh, Marrakesh, Morocco
  • 17 Department of Urology, Federal University of Paraná, School of Medicine, Hospital das Clínicas, Curitiba, Brazil
  • 18 Department of Urology, Hospital Médica Sur, Mexico City, Mexico
  • 19 Department of Urology, Hospital Yalgado Ouedraogo Ouagadouga, Kadiogo, Burkina Faso
  • 20 Department of Urology, Hospital Das Clínicas da Universidade de São Paulo, Sao Paulo, Brazil
  • 21 Department of Urology, AIIMS, Bhubaneshwar, India
  • 22 Department of Urology, Hospital Municipal Dr. Moysés Deutsch (M'Boi Mirim), Sao Paulo, Brazil
  • 23 Department of Urology, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Polytechnic University of Le Marche Region, Ancona, Italy
  • 24 Department of Minimally Invasive Urology, Ng Teng Fong General Hospital, Singapore, Singapore
Curr Urol, 2024 Mar;18(1):55-60.
PMID: 38505163 DOI: 10.1097/CU9.0000000000000163

Abstract

BACKGROUND: Emphysematous pyelonephritis (EPN) is a necrotizing infection of the kidney and the surrounding tissues associated with considerable mortality. We aimed to formulate a score that classifies the risk of mortality in patients with EPN at hospital admission.

MATERIALS AND METHODS: Patients diagnosed with EPN between 2013 and 2020 were retrospectively included. Data from 15 centers (70%) were used to develop the scoring system, and data from 7 centers (30%) were used to validate it. Univariable and multivariable logistic regression analyses were performed to identify independent factors related to mortality. Receiver operating characteristic curve analysis was performed to construct the scoring system and calculate the risk of mortality. A standardized regression coefficient was used to quantify the discriminating power of each factor to convert the individual coefficients into points. The area under the curve was used to quantify the scoring system performance. An 8-point scoring system for the mortality risk was created (range, 0-7).

RESULTS: In total, 570 patients were included (400 in the test group and 170 in the validation group). Independent predictors of mortality in the multivariable logistic regression were included in the scoring system: quick Sepsis-related Organ Failure Assessment score ≥2 (2 points), anemia, paranephric gas extension, leukocyte count >22,000/μL, thrombocytopenia, and hyperglycemia (1 point each). The mortality rate was <5% for scores ≤3, 83.3% for scores 6, and 100% for scores 7. The area under the curve was 0.90 (95% confidence interval, 0.84-0.95) for test and 0.91 (95% confidence interval, 0.84-0.97) for the validation group.

CONCLUSIONS: Our score predicts the risk of mortality in patients with EPN at presentation and may help clinicians identify patients at a higher risk of death.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications